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TNF receptor associated factor 2 (TRAF2) plays a very important role in cellular innate immune as well as
inﬂammatory responses. Previous studies have reported TRAF2 mediated regulation of TNF and
Interferon (IFN) induced canonical and non-canonical activation of NFκB. In this study, we show that
rotavirus NSP1 targets TRAF2 to regulate IFN induced non-canonical NFκB activation. Here we found that
rotavirus Non-Structural Protein-1 (NSP1) interacts with TRAF2 and degrades it in a proteasome
dependent manner. C-terminal part of NSP1 was sufﬁcient for interacting with TRAF2 but it alone could
not degrade TRAF2. This inhibition of interferon mediated non-canonical NFκB activation by NSP1 may
modulate inﬂammatory cytokine production after rotavirus infection to help the virus propagation.
& 2013 Elsevier Inc. All rights reserved.Introduction
Rotavirus (RV), the major cause of severe infantile gastroenter-
itis, is icosahedral in structure with three concentric layers of
proteins and a genome of 11 dsRNA segments (Estes and Kapikian,
2007). The virus contains six structural proteins (VP1-4, VP6-7)
which forms the virion, it also encodes six non-structural proteins
(NSP1-6). NSP1, a RNA binding protein (Estes and Kapikian, 2007),
is the only rotavirus protein implicated in evasion of innate
immune response by counteracting induction of interferon (IFN)
and delaying early cellular apoptosis by activation of PI3K/Akt
pathway (Feng et al., 2009; Barro and Patton, 2007; Bagchi et al.,
2010, 2013). Among group A rotaviruses, NSP1 is highly variable
(Hua et al., 1993), except for a conserved N-terminus cystein rich
motif (C-X2-C-X8-C-X2-C-X3-H-X-C-X2-C-X-5-C) which is a puta-
tive zinc ﬁnger motif. Since this region is conserved, it has been
postulated that it may have an important role in function of the
protein. C-terminus of NSP1 has an IRF3 binding site and has been
shown to involve in IRF3 degradation (Barro and Patton, 2007).
However both N-terminal and C-terminal part of NSP1 were
shown to be important for PI3K/Akt activation (Bagchi et al.,
2013). Here in this study we are focusing on another role of RVll rights reserved.
opmental Biology, University
A.NSP1 to counteract host immunity. TRAFs (TNF receptor associated
factors) function as adapter molecules for TNF superfamily mem-
bers and regulate downstream signaling events like NFκB and AP-1
activation (Hsu et al., 1996). TRAF proteins play critical role in
inﬂammatory processes, programmed cell death and interferon
responses (Hacker et al., 2006; Saha et al., 2006; Chuan et al.,
2008). E3 ubiquitin ligase family protein A20 interacts with TRAF2
(TNF receptor associated factor 2) and degrades it (Li et al., 2009).
Based on microarray analysis, induction of A20 in different wild
type RV strains (SA11, Wa, A5-13) was observed (Bagchi et al.,
2012). So we tried to analize TRAF2 degradation in RV
infected cells.Material and methods
Reagents
Proteasomal inhibitor MG132 and interferon β were purchased
from Sigma–Aldrich (St. Louis, MO, USA) and Invivogen (San Diego, CA,
USA) and used at a concentration of 5 mM and 1000 U/ml respectively.
siRNA for TRAF2 and control siRNA was from Ambion (NY, USA).
Cell culture and virus infection
Human intestinal epithelial (HT29) and human embryonic kidney
epithelial (HEK 293T) cell lines were cultured in Dulbecco′s modiﬁed
Eagle′s medium (DMEM) supplemented with 10% fetal bovine serum
and 1% antibiotic–antimycotic solution (Invitrogen, Carlsbad, CA).
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bovine rotavirus wild type A5-13 and NSP1 mutant A5-16 strains
(Taniguchi et al., 1996) (accession numbers D38148; D38149) were
used in the study. For infection, viruses were activated with acety-
lated trypsin (10 μg/ml) at 37 1C for 30 min, diluted as per required
multiplicity of infection (MOI) and added to the cells for adsorption
(45 min) at 37 1C, followed by washing 3X with media to remove
unbound virus. Infection was continued in fresh medium. MOI 2 of
virus was used for HT29 cells in the study. The time of virus removal
was taken as 0 h post infection (hpi) for all experiments. At different
time points cells were freeze-thawed for cell lysis. Extracted and
puriﬁed viral preparations were titrated by plaque assay (Bagchi et.
al., 2010).
Gel electrophoresis and immunoblot analyses
Gel electrophoresis and immunoblot assay was performed as
previously described (Bagchi et. al., 2010). TRAF2 antibody, A20
antibody and Anti-His antibody was from Santa Cruz Biotechnol-
ogy, CA. GAPDH, NFκB p52 antibody and ﬂuorescent tagged
secondary antibodies were purchased from Cell Signaling Inc,
Devers, MA and Invitrogen, USA respectively. RV NSP3 and NSP1
antibody were raised in our lab. Blots were scanned and quanti-
tated using GelDoc XR system and Quantity Ones software version
4.6.3 (BioRad, Hercules, CA).
Cloning
C-terminal His-tagged full length NSP1 construct was made by
cloning NSP1 in pcDNA6 vector (Invitrogen, USA) as previously
described (Bagchi et. al., 2010). pcDNSP1N and pcDNSP1C was
developed by cloning N terminal (1–100 amino acid) and C
terminal (101 amino acid to end) NSP1 in pcDNA6 vector respec-
tively. Full length TRAF2 was cloned in pFLAG vector (Sigma, MO)
to make FLAG tagged TRAF2 construct.Fig. 1. Rotavirus NSP1 degrades TRAF2 in a proteasome dependent manner. (A) HT29
lysates were taken at indicated time points for western blotting with TRAF2 antibody an
antibody as a marker of RV infection. The band intensity of TRAF2, A20 and NSP3 were n
(B) HEK293 cells were transfected with either empty vector or with pFlag-NSP1 and ce
TRAF2 antibody. Blots were reprobed with GAPDH as loading control and NSP1. (C) H
inhibitor MG132. At indicated time after infection cell lysates were western blotted wi
All experiments are representative of three independent experiments.Nuclear protein extraction
HEK 293T cells were transfected with respective DNA con-
structs or siRNAs by Lipofectamine method (Invitrogen, USA) and
either treated or mock treated with interferon β and nuclear
extracts were prepared with ProteoJET Cytoplasmic and Nuclear
Protein Extraction Kit (Fermentas Life Science, USA) for NFκB p52
translocation studies.Immunoprecipitation
Immunoprecipitation experiments were performed as described
previously (Bagchi et. al., 2010).Immunoﬂuorescence microscopy
Cos7 cells were co-transfected either with Flag-TRAF2, pcDNSP1 or
Flag-TRAF2, pcDNA and after 16 hours cells were ﬁxed with parafor-
maldehyde (4% w/v in PBS) for 10 min at RT and permeabilized with
0.1% triton X-100 for 20 min at 4 1C and probed with speciﬁc primary
(anti-FLAG and anti NSP1) at 1:200 dilution and ﬂuorescent tagged
secondary antibodies (anti-mouse FITC, anti-rabbit Rhodamine) at
1:100 dilution. After 5X PBS wash, slides were mounted with
Vectashield-DAPI (Vector laboratories, Burlingame, CA, USA) and
examined under ﬂuorescence-microscope (Carl Zeiss, Gottingen, Ger-
many). Excitation and emission detection for each ﬂuor was per-
formed sequentially to avoid cross-talk.Statistical analysis
Data are expressed as mean7standard deviations of at least
three independent experiments (n≥3). In all tests, po0.05 was
considered statistically signiﬁcant.cells were mock infected or infected with either A5-13 or A5-16 at MOI 2 and cell
d A20 antibody. Blots were reprobed with GAPDH as loading control and RV NSP3
ormalized against GAPDH. The data represent the means7the standard deviation.
ll lysates were taken at indicated time after transfection and western blotted with
T29 cells were mock infected or infected with A5-13 in presence of proteasomal
th TRAF2 antibody. Blots were reprobed with GAPDH as loading control and NSP1.
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To delineate the mechanism by which RV may degrade TRAF2,
HT29 cells were either mock infected or infected with wild type
bovine RV strain A5-13 (MOI 2) or its isogenic NSP1 mutant strain
A5-16 (MOI 2). Time course study showed TRAF2 degradation in A5-
13 infected cells from 4hpi whereas in A5-16 infected cells, there
was no TRAF2 degradation however A20 is induced by both
strains (Fig. 1A). Other RV strains with functional NSP1 such as
SA11( simian) and OSU ( porcine) also resulted in degradation of
TRAF2 suggesting it to be a strain independent phenomenon
(Supplementary Fig. S1). To study whether in addition to NSP1,
other RV proteins also play a role in TRAF2 degradation, HEK293
cells were transfected with either empty vector or pcDNSP1 and cell
lysates were prepared at increasing time points. Immunoblotting for
TRAF2 revealed time dependent decrease in TRAF2 expression
suggesting that in absence of other viral proteins, NSP1 alone is
sufﬁcient for TRAF2 degradation (Fig. 1B). Since NSP1 has been
reported to have putative E3 ubiquitin ligase like activity (Graff et al.,
2007), TRAF2 degradation was analyzed in presence of proteasomal
inhibitor MG132. In HT29 cells infected with A5-13 strain in
presence of MG132 (5 mM), TRAF2 degradation was not observed,
suggesting it to be proteasome dependent activity (Fig. 1C).
To investigate whether NSP1 interacted with TRAF2, ﬁrst HT29
cells were infected with A5-13 and cell lysates were immunopre-
cipitated with TRAF2 antibody or rabbit serum as control. As shown
in Fig. 2A, NSP1 co-immunoprecipitated with TRAF2. Interaction of
NSP1 with TRAF2 was further conﬁrmed when NSP1 (His-tagged,
cloned in pcDNA6 vector, Invitrogen) co-immunoprecipitated with
TRAF2 (Flag tagged, cloned in pFLAG vector, Sigma) in HEK 293 cellsFig. 2. Rotavirus NSP1 interacts with TRAF2 and causes its degradation. (A) HT29 cel
TRAF2 antibody (1:500 dilution) and western blotted with raised antibody against RV NS
293 cells were co-transfected with pFlag-TRAF2, pcDNSP1, immunoprecipitated with eith
TRAF2 antibody which further conﬁrms positive interaction between NSP1 and TRAF2. (C
NSP1. Nucleus was stained with DAPI. (D) HEK 293 cells were either co-transfected with
rabbit serum or with Anti-His antibody (1:500 dilution) and western blotted with TR
(E) HEK293 cells were either transfected with empty vector or pcDNSP1 or pcDNSP1N o
with GAPDH as loading control. The band intensity of TRAF2 was normalized against Goverexpressing these proteins (Fig. 2B). Co-localization of NSP1 and
TRAF2 was also observed by immunoﬂuorescence microscopy
(Fig. 2C). Once interaction between the two proteins was conﬁrmed,
region of NSP1 (N-terminal or C-terminal) responsible for this
interaction was analyzed. HEK293 cells were co-transfected with
either Flag-TRAF2 and pcDNSP1N (N-terminal 1–100 amino acids)
or Flag-TRAF2 and pcDNSP1C (C-terminal 101-end) and immuno-
precipitated with either rabbit serum as control or with anti-His
antibody. As shown in Fig. 2C, C-terminal region of NSP1 co-
immunoprecipitated with TRAF2, whereas no interaction between
NSP1N and TRAF2 was observed. To analyze whether C-terminal
NSP1 was sufﬁcient for TRAF2 degradation, HEK293 cells were
transfected with either empty vector or full length pcDNSP1 or
pcDNSP1N or pcDNSP1C and after 24 h cell lysates were immuno-
blotted with TRAF2 antibody. Unlike interaction studies (Fig. 2C), N-
terminal or C-terminal region of NSP1 could not degrade TRAF2
(Fig. 2D) whereas TRAF2 degradation was observed in NSP1 (full
length) expressing cells (Fig. 2D). This suggested that NSP1-C
terminal region may bind to TRAF2, but N-terminal region is also
required for degradation. This is consistent with previous reports on
NSP1 mediated degradation of IRF3. It can be hypothesized that
NSP1C binds to TRAF2 which is ubiquitinylated by putative E3
ubiquitin ligase activity of NSP1-N terminal domain followed by
proteasomal degradation.
Once the TRAF2 degradation by NSP1 was conﬁrmed, its
signiﬁcance during rotavirus infection was analyzed. TRAF2 plays
an important role in IFN mediated non-canonical NFκB activation
by facilitating p65-p52 interaction leading to their nuclear trans-
location (Chuan et al., 2008), HEK293 cells were transfected with
either empty vector or Flag-NSP1 or siTRAF2 or control siRNAls were infected with A5-13, immunoprecipitated with either rabbit serum or with
P1 antibody which showed positive interaction between NSP1 and TRAF2. (B) HEK
er rabbit serum or with Anti-His antibody (1:500 dilution) and western blotted with
) Immunoﬂuorescence microscopy data showed clear co-localization of TRAF2 with
Flag-TRAF2, pcDNSP1N or Flag-TRAF2, pcDNSP1C, immunoprecipitated with either
AF2 antibody which indicated that TRAF2 interacts with C-terminal part of NSP1.
r pcDNSP1C and cell lysates were western blotted with TRAF2. Blots were reprobed
APDH. All experiments are representative of three independent experiments.
Fig. 3. NSP1 inhibits interferon mediated NFκB p52 activation. (A) HEK293 cells were either transfected with empty vector or Flag-NSP1 or TRAF2 siRNA (80 pmole) or
control siRNA in presence or absence interferon β. Western blot of nuclear extract with NFκB p52 antibody was performed to detect nuclear localized p52. Blot was reprobed
with PCNA as loading control and with GAPDH to inquire about the presence of any cytosolic fraction. (B) Functionality of TRAF2 siRNA was checked using two concentration
(50 pmole and 80 pmole). Blots were reprobed with GAPDH as loading control. All experiments are representative of three independent experiments.
P. Bagchi et al. / Virology 444 (2013) 41–4444individually and treated with interferon β (1000 U/ml) for 30 min
In addition IFN β untreated and empty vector transfected HEK293
cell was also analyzed. Nuclear lysates were immunoblotted with
anti p52 showed that RV NSP1 inhibits the IFN β mediated nuclear
translocation of NFκB p52 (Fig. 3A). Down regulation of TRAF2 by
siRNA also resulted in inhibition of interferon induced NFκB p52
nuclear translocation (Fig. 3A, B). No degradation of TRAF2 was
observed in either empty vector or control siRNA transfected cells.Conclusion
Many other viruses have also been shown to interact with
TRAF2 to regulate NFκB activation (Choi et al., 2006; Park et al.,
2002; Yang et al., 2008; Song & Kang, 2010). Previous studies have
shown that RV NSP1 antagonizes IFN by degradation of IRFs and
RIG1 (Graff et al., 2007; Qin et al., 2011), however still signiﬁcant
amount of IFNβ is induced in RV infected cells (Bagchi et al., 2010).
Here we report that RV NSP1 not only interacts with, but also
degrades TRAF2 resulting in inhibition of interferon induced
non-canonical NFκB activation which may antagonize virus
induced cellular cytokine responses to facilitate virus propagation
(Toby, 2009). Overall this study highlights one of the many
strategies by which RV NSP1 counteracts host response.Acknowledgments
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